At Fluid-Screen we believe that people and companies make better decisions when they have access to the right information. These decisions impact their health, the well-being of their families, enabling them to work more efficiently.
Our artificial intelligence-based microchip technology provides information about bacteria present in fluid samples in minutes instead of days. We help our partners, pharmaceutical companies, accelerate development and manufacturing of new therapeutics. It is time they get access to the right information when they need it.
Fluid-Screen has raised over 7 million USD Series A round of financing. Our goal is to bring a family of products to market that will fundamentally improve the pharmaceutical manufacturing process. We are currently engineering our first prototype systems which will be deployed for validation testing at up to five identified customers.
Overview
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Persons 1
| Date | First Name | Last Name | Title | |||
| Sign up to see | Sign up to see | Sign up to see | Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 1
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
Reviews 0
FAQ about Fluid-Screen
When was Fluid-Screen founded?
Fluid-Screen was founded in 2015.
Is Fluid-Screen still active?
Yes, Fluid-Screen is active; its latest activity on Parsers VC dates from Feb 1, 2016.